X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs CADILA HEALTHCARE - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD CADILA HEALTHCARE WYETH LTD/
CADILA HEALTHCARE
 
P/E (TTM) x 27.7 32.8 84.6% View Chart
P/BV x 5.3 6.5 82.4% View Chart
Dividend Yield % 1.3 0.7 175.7%  

Financials

 WYETH LTD   CADILA HEALTHCARE
EQUITY SHARE DATA
    WYETH LTD
Mar-13
CADILA HEALTHCARE
Mar-17
WYETH LTD/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,044460 227.0%   
Low Rs818305 268.2%   
Sales per share (Unadj.) Rs298.692.1 324.1%  
Earnings per share (Unadj.) Rs57.214.8 386.3%  
Cash flow per share (Unadj.) Rs58.418.5 316.1%  
Dividends per share (Unadj.) Rs17.003.20 531.3%  
Dividend yield (eoy) %1.80.8 218.2%  
Book value per share (Unadj.) Rs249.568.0 366.9%  
Shares outstanding (eoy) m22.721,023.74 2.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.2 75.1%   
Avg P/E ratio x16.325.8 63.0%  
P/CF ratio (eoy) x15.920.7 77.0%  
Price / Book Value ratio x3.75.6 66.3%  
Dividend payout %29.721.6 137.5%   
Avg Mkt Cap Rs m21,157391,581 5.4%   
No. of employees `0000.516.9 2.9%   
Total wages/salary Rs m40015,002 2.7%   
Avg. sales/employee Rs Th13,787.45,594.5 246.4%   
Avg. wages/employee Rs Th813.0890.1 91.3%   
Avg. net profit/employee Rs Th2,643.3899.9 293.7%   
INCOME DATA
Net Sales Rs m6,78394,295 7.2%  
Other income Rs m3531,286 27.4%   
Total revenues Rs m7,13695,581 7.5%   
Gross profit Rs m1,61719,036 8.5%  
Depreciation Rs m273,750 0.7%   
Interest Rs m6450 1.2%   
Profit before tax Rs m1,93816,122 12.0%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5-3 170.0%   
Tax Rs m6321,289 49.0%   
Profit after tax Rs m1,30115,168 8.6%  
Gross profit margin %23.820.2 118.1%  
Effective tax rate %32.68.0 408.0%   
Net profit margin %19.216.1 119.2%  
BALANCE SHEET DATA
Current assets Rs m6,98460,223 11.6%   
Current liabilities Rs m2,05653,058 3.9%   
Net working cap to sales %72.67.6 956.1%  
Current ratio x3.41.1 299.3%  
Inventory Days Days9970 142.2%  
Debtors Days Days2488 27.2%  
Net fixed assets Rs m24472,984 0.3%   
Share capital Rs m2271,024 22.2%   
"Free" reserves Rs m5,44168,576 7.9%   
Net worth Rs m5,66869,600 8.1%   
Long term debt Rs m2524,684 0.1%   
Total assets Rs m7,901152,207 5.2%  
Interest coverage x353.336.8 959.4%   
Debt to equity ratio x00.4 1.2%  
Sales to assets ratio x0.90.6 138.6%   
Return on assets %16.510.3 161.1%  
Return on equity %22.921.8 105.3%  
Return on capital %34.017.9 189.9%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1521,280 0.1%   
Fx outflow Rs m2,67710,874 24.6%   
Net fx Rs m-2,66210,406 -25.6%   
CASH FLOW
From Operations Rs m92313,495 6.8%  
From Investments Rs m317-29,103 -1.1%  
From Financial Activity Rs m-48123,158 -2.1%  
Net Cashflow Rs m7597,556 10.0%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 8.3 136.1%  
FIIs % 7.2 5.9 122.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 11.0 276.4%  
Shareholders   21,978 44,069 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  CIPLA  TORRENT PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Market at Record Highs; Strong ITC & RIL Performance & Other Top Cues to Sway the Market Today(Pre-Open)

Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services. At the closing bell last week.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS